Brief: Inspira Collaborates With Ennocure To Develop Treatment To Prevent Associated Bloodstream Infections In ICU Patients
29/11/2023 16:09
Nov 29 (Reuters) - Inspira Technologies Oxy BHN Ltd
IINN.O :
* INSPIRA COLLABORATES WITH ENNOCURE FOR DEVELOPMENT OF A
PROPRIETARY BIO-ELECTRONIC TREATMENT TO PREVENT ASSOCIATED
BLOODSTREAM INFECTIONS IN ICU PATIENTS
Source text for Eikon: ID:nPn1LRrB0a
Further company coverage: IINN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Qtrex Quantum
See all newsBrief: Qtrex Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Requirement
Brief: Qtrex Quantum Ltd In Discussions With A US Department Of Defense’S Research Laboratory To Establish A Joint Quantum Development Program
Brief: Qtrex Quantum - Offers Up To 6.8 Million Ordinary Shares For Resale By Selling Shareholder - SEC Filing
Brief: Qtrex Expands Into Quantum Processor Interface With Single-Build Cryogenic Chip Carrier
NASDAQ RESUMED AT 11:03 AM